metricas
covid
Buscar en
Gastroenterología y Hepatología
Toda la web
Inicio Gastroenterología y Hepatología ¿Cuándo sería más rentable realizar una endoscopia digestiva alta para estab...
Información de la revista
Vol. 27. Núm. 6.
Páginas 353-356 (enero 2004)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 27. Núm. 6.
Páginas 353-356 (enero 2004)
Acceso a texto completo
¿Cuándo sería más rentable realizar una endoscopia digestiva alta para establecer la presencia de varices esofágicas en pacientes con cirrosis?
When is the best time to perform upper digestive endoscopy to detect the presence of esophageal varices in patients with cirrhosis?
Visitas
4440
R. Adrovera,
Autor para correspondencia
raul_adrover@sinectis.com.ar

Correspondencia: Dr. R. Adrover. C/ 493 bis, 2149 Gonnet (1897). Buenos Aires. Argentina.
, D. Cocozzellaa, S. Borzia, L. Montenegrob, M. Defelittob, D. Bosiac, E. Fraquellic, J. Curciarelloc
a Sección de Hepatología. Hospital Interzonal General de Agudos Prof. Dr. Rodolfo Rossi. La Plata
b Servicio de Radiología. Hospital Interzonal General de Agudos Prof. Dr. Rodolfo Rossi. La Plata
c Servicio de Gastroenterología. Hospital Interzonal General de Agudos Prof. Dr. Rodolfo Rossi. La Plata. Argentina
Este artículo ha recibido
Información del artículo
Introduccion

La hemorragia varicosa ocurre en el 25 al 35% de los pacientes cirróticos y está asociada con una morbimortalidad significativa y mayores costes hospitalarios. El estudio endoscópico de varices esofagogástricas (VEG) en los pacientes cirróticos incrementa los costes, tiene cierto grado de invasividad y provoca malestar en los pacientes. La asociación de la presencia de VEG con el tamaño esplénico, la función hepática y el recuento de plaquetas es controvertida.

Realizamos este estudio para conocer la correlación entre la funcionalidad hepática, evaluada mediante la clasificación de Child-Pugh, el recuento de plaquetas y el índice volumétrico esplénico con la presencia de VEG, en pacientes con cirrosis asistidos de forma ambulatoria.

Pacientes Y Metodo

A los 68 enfermos incluidos se les realizaron: historia clínica, pruebas bioquímicas, ecografía abdominal en modo B y Doppler, además de una videoendoscopia digestiva alta.

Resultados

El 76,47% de los pacientes eran varones y el 23,53%, mujeres. La mediana de edad (± desviación estándar) fue de 52,8 ± 12,4 años. Según la clasificación de Child-Pugh, el 54,41% pertenecía al grupo a A, el 41,18% al B y el 4,41% al C. Las causas más frecuentes de cirrosis fueron el consumo de alcohol (52,95%) y el virus de la hepatitis C (17,65%). Se encontraron varices esofágicas en el 85,29% de los pacientes. La mediana del índice volumétrico esplénico fue de 50,5 ± 9,2 y la mediana del recuento de plaquetas, de 150 ± 26 × 109/l. Se halló correlación entre la presencia de varices esofágicas, índice volumétrico esplénico ≥ 45 y recuento de plaquetas ≤ 100 × 109/l (r = 0,327; p = 0,006), pero no entre la presencia de varices esofágicas y el grado de Child-Pug A.

En el análisis multivariado, sólo la presencia de varices esofágicas se asoció a un índice de volumen esplénico ≥ 45 (odds ratio de 7,4; intervalo de confianza del 95%, 1,30-77,7; p = 0,02).

Conclusion

La presencia de varices esofágicas en pacientes cirróticos asistidos de forma ambulatoria se correlacionó con un índice volumétrico esplénico ≥ 45 y un recuento de plaquetas ≤ 100 × 109/l.

Introduction

Variceal hemorrhage occurs in 25 to 35% of cirrhotic patients and is associated with significant morbidity and mortality and elevated hospital costs. Endoscopic exploration of gastroesophageal varices (GEV) in cirrhotic patients increases costs and involves a certain degree of invasiveness and discomfort for patients. The association between the presence of GEV and spleen size, liver function and platelet count is controversial.

The aim of this study was to determine the correlation between liver function, evaluated by Child-Pugh (Ch-P) classification, platelet count (PC) and spleen volume index (SVI) with the presence of GEV in patients with cirrhosis managed in the outpatient setting.

Patients And Method

Sixty-eight patients were included. In all patients, a medical history was taken and biochemical tests, mode B and Doppler abdominal ultrasonography, and upper digestive video-endoscopy were performed.

Results

A total of 76.47% of the patients were men and 23.53% were women. The median age was 52.8 ± 12.4 years. More than half (54.41%) of the patients were Ch-P grade A, 41.18% were grade B and 4.41% were grade C. The most frequent causes of cirrhosis were alcohol in 52.95% and hepatitis C virus in 17.65%. Esophageal varices (EV) were found in 85.29% of the patients. The median SVI was 50.5 ± 9.2 and the median PC was 150 ± 26 × 109/L. A correlation was found between the presence of EV, SVI ≥ 45 and PC ≤ 100 × 109/L (r = 0.327; p = 0.006). No correlation was found between the presence of EV and Ch-P grade A. In the multivariate analysis, only the presence of EV was associated with SVI ≥ 45 (OR 7.4; 95% CI, 1.30-77.7; p = 0.02).

Conclusion

The presence of EV in cirrhotic patients managed in the outpatient setting was correlated with SVI ≥ 45 and PC ≤ 100 × 109/L.

El Texto completo está disponible en PDF
Bibliografía
[1.]
M. Peck-Radosavljevic, J. Zachrl, G. Meng, et al.
Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver?.
J Hepatol, 27 (1997), pp. 127-131
[2.]
L.E. Adinolfi, M.G. Giordano, A. Andreana, et al.
Hepatic fibrosis plays a central rol in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis.
Br J Haematol, 113 (2001), pp. 590-595
[3.]
G.J. Gores, R.H. Wiesner, E.R. Dickson, et al.
Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival.
Gastroenterology, 96 (1989), pp. 1552-1559
[4.]
R.J. Groszmann, J. Bosch, N.D. Grace, et al.
Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage.
Gastroenterology, 99 (1990), pp. 1401-1407
[5.]
The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices.
Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study.
N Engl J Med, 319 (1988), pp. 983-989
[6.]
R. De Franchis, M. Primignani.
Natural history of portal hypertension in patients with cirrhosis.
Clin Liver Dis, 5 (2001), pp. 645-663
[7.]
A.K. Burroughs, P.A. McCormick.
Natural history and prognosis of variceal bleeding.
Baillieres Clin Gastroenterol, 2 (1992), pp. 437-450
[8.]
I.M. Gralnek, D.M. Jensen, T.O.G. Kovacs, et al.
The economic impact of esophageal variceal hemorrhage: cost-effectiveness implications of endoscopic therapy.
Hepatology, 29 (1999), pp. 44-50
[9.]
J.P. Cello, J.H. Grendell, R.A. Crass, et al.
Endoscopic scleropathy versus portocaval shunt in patients with severe cirrhosis and acute variceal hemorrhage: long-term follow-up.
N Engl J Med, 316 (1987), pp. 11-15
[10.]
A. Wysocki, M. Pozniczek, A. Budzynski.
Determination of blood cell count and spleen size in patients with liver cirrhosis submitted to endoscopic sclerotherapy for esophageal varices.
Prze Gl Lek, 56 (1999), pp. 653-655
[11.]
F. Schepis, C. Camma, D. Niceforo, et al.
Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection?.
Hepatology, 33 (2001), pp. 333-338
[12.]
F.H. Ng, S.Y. Wong, C.K. Loo.
Prediction of oesophagogastric varices in patients with liver cirrhosis.
J Gastroenterol Hepatol, 14 (1999), pp. 785-790
[13.]
A. Zaman, R. Hapke, K. Flora, et al.
Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease.
Am J Gastrenterol, 94 (1999), pp. 3292-3296
[14.]
R. Madhotra, H.E. Mulcahy, I. Willner, A. Reuben.
Prediction of esophageal varices in patients with cirrhosis.
J Clin Gastroenterol, 34 (2002), pp. 81-85
[15.]
F. Oberti, E. Valsesia, C. Pilette, et al.
Noninvasive diagnosis of hepatic fibrosis or cirrhosis.
Gastroenterology, 113 (1997), pp. 1609-1616
[16.]
H. Pietri, M. Boscaini.
Determination of a splenic volumetric index by ultrasonic scanning.
Ultrasound, 3 (1984), pp. 19-23
[17.]
Japanese Research Society for Portal Hypertension.
The general rules for recording endoscopic findings on esophageal varices.
Jpn J Surg, 10 (1980), pp. 84
[18.]
L.A. Beppu, K. Inokuchi, N. Koyanagi, et al.
Prediction of variceal hemorrhage by esophageal endoscopy.
Gastrointest Endosc, 27 (1981), pp. 213-218
[19.]
N.D. Grace, R.J. Groszman, G. García-Tsao, et al.
Portal hypertension and variceal bleeding: an AASLD single topic symposium.
Hepatology, 28 (1998), pp. 868-880
[20.]
R. De Francis.
Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension.
J Hepatol, 33 (2000), pp. 846-852
[21.]
S. Watanabe, N. Hosomi, Y. Kitade, et al.
Assessment of the presence and severity of esophagogastric varices by splenic index in patients with liver cirrrhosis.
J Comut Assist Tomogr, 24 (2000), pp. 788-794
[22.]
A. Zaman, T. Becker, J. Lapidus, K. Benner.
Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage.
Arch Intern Med, 161 (2001), pp. 2564-2570
[23.]
M. Zoli, C. Merkel, D. Magalotti, et al.
Natural history of cirrhotic patients with small esophageal varices: a prospective study.
Am J Gastroenterol, 95 (2000), pp. 503-508
[24.]
P. Cales, C. Zabotto, C. Meskens, et al.
Gastroesophageal endocopic features in cirrhosis: observer variability, interassociations and hepatic dysfunction.
Gastroenterology, 98 (1990), pp. 156-162
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos